We are interested in understanding delivery barriers at the molecular level. We are developing tools that allow us to achieve that.

We are designing novel and efficient genetically encoded delivery systems by integrating knowledge from synthetic biology, functional genomics and protein engineering.

We aim to advance gene editing systems such as Cas9 nuclease, base editors and prime editors as next generation therapeutics.

We are intrigued by the biological contributions of transposable elements across various diseases. So, we are developing highly parallel methods using CRISPR-based gene-editing systems to dissect these contributions to inspire new therapeutic strategies.